UAE fast-tracks approval of Blenrep, pioneering treatment for multiple myeloma

Junshi Biosciences Announces the Acceptance of the sNDA for Toripalimab as the 1st-line Treatment of...

PADCEV™ Plus KEYTRUDA™ Significantly Improves Survival for Certain Patients with Bladder Cancer When Given Before...

Idience and Aptis collaborate to develop next-generation dual payload ADC cancer drug

Cohance Lifesciences announces $10 M investment in cGMP Bioconjugation Suite in US

Ipsen hands back Sutro’s ROR1 ADC at center of $875M deal